Reposted by Gabrijela Dumbović
In this preprint we describe new ASOs targeting telomerase RNA hTR. These ASOs are potent inhibitors of telomerase in vitro and induce telomere shortening with reduced proliferation in cancer cells.
A new tool for telomere biology studies and a promising chemistry for cancer therapies. Check it out!